Podcast Index
Browse podcasts by category, open recent episodes, and download audio to listen offline.
Hematologic Oncology Update
Dr. Neil Love
No Trade Secrets
Jarome McKenzie
Science's Not Boring
Kidopoly
Book Shelter
Book Shelter
CyberSecurity Summary
CyberSecurity Summary
GRIEF: Let's Make Sense of This Sh*t
Dylan
Historias de los Libros
Historias de los Libros
Medicine Made Simple
Medicine Made Simple
C-PTSD: Let's Make Sense Of This Sh*t
Gregory
Dentistry Made Simple
Dentistry Made Simple
CyberCode Academy
CyberCode Academy
Civil Engineering Made Simple
Civil Engineering Made Simple
Storytime for Kids
Storytime for Kids
Morning and Evening with Charles Spurgeon
ClassicDevotionals.com
Reimagine Childhood
Early Childhood Christian Network
Everyday
Kellen De Vos
Caffe 2.0
Valentino Spataro
Reflex — PM&R Board Review
Reflex / Z. Shumaker, MD
Your World of Creativity
Mark Stinson
Power & Purpose
IE Insights - Hosted by Amanda Sloat and Nathalie Tocci
Українська - це просто на Хіт FM
Олена Зінченко, Анна Лісовська, hitfm.ua
Dialoghi
teisasa
EyeCode Media
Christopher Wolfe, OD, FAAO, Dipl. ABO
Talking Wealth Podcast: Stock Market Trading and Investing Education | Wealth Creation | Expert Share Market Analysis
Dale Gillham: Share Market Analyst, Share Market Educator, Professional Trader and Investor
English with Frazer - LEARN NATURAL BRITISH ENGLISH
Frazer W
.png)
Japanese podcast for beginners (Nihongo con Teppei)
Japanese podcast for beginners (Nihongo con Teppei)
リセマム 最新教育情報
株式会社イード
the $100k healer: the audio roadmap for clinicians building a coaching business that generates real online income and makes the world more whole.
Chelsea Turgeon
Cat & Cloud Podcast
Cat & Cloud
The Faith Xperience with André Butler
Faith Xperience Church
The Treadweary Podcast
Carleton Smee
Optimal Living Daily - Personal Development and Self-Improvement
Justin Malik
New Mindset, Who Dis?
Case Kenny
Parenting Today's Teens
Mark Gregston
Focus on This
Full Focus
Happier with Gretchen Rubin
Gretchen Rubin / The Onward Project
Change Wired
Angela Shurina
Education
Dr. Neil Love
Featuring perspectives from Dr Courtney D DiNardo and Dr Harry Paul Erba, including the following topics:Introduction (0:00)Current Management Approaches for FLT3- and IDH-Mutated Acute Myeloid Leukemia (AML) — Dr DiNard...
Featuring perspectives from Dr Anthony M Hunter and Dr Abdulraheem Yacoub, including the following topics:Introduction (0:00)Systemic Mastocytosis — Dr Hunter (9:33)Myelofibrosis — Dr Yacoub (29:40)CME information and se...
Featuring perspectives from Dr Hans Lee and Dr Noopur Raje, including the following topics:Introduction (0:00)Integrating Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies into the Management of Relapsed...
Featuring perspectives from Dr John N Allan and Dr Adam Kittai, including the following topics:Introduction (0:00)Current Management of Newly Diagnosed Chronic Lymphocytic Leukemia — Dr Allan (8:47)Noncovalent Bruton Tyr...
Featuring perspectives from Dr Manali Kamdar, Dr Krish Patel and Dr Gilles Salles, including the following topics:Introduction (0:00)Antibody-Drug Conjugates and Other Novel Strategies for the Management of Diffuse Large...
Dr Jennifer R Brown and Prof Wojciech Jurczak discuss the selection and sequencing of Bruton tyrosine kinase-targeted therapy for patients with chronic lymphocytic leukemia and summarize major advances in the treatment l...
Dr Amir Fathi from Massachusetts General Hospital in Boston, Massachusetts, and Dr Eunice S Wang from Roswell Park Comprehensive Cancer Center in Buffalo, New York, discuss key clinical trial data surrounding the use of ...
Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.CM...
Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatm...
Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.CM...
Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatm...
Dr Bijal Shah from Moffitt Cancer Center in Tampa, Florida, discusses the role of BiTEs in the management of ALL.CME information and select publications here.
Prof Constantine Tam from Monash University in Melbourne, Australia, reviews recent datasets and discusses their implications for current and future management of chronic lymphocytic leukemia.CME information and select p...
Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatm...
Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatm...
Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the m...
Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 20...
Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston, Dr Cindy Neunert from Columbia University Irving Medical Center in New York and Prof Francesco Zaja from ASUGI in Trieste, Italy discuss cases of immune ...
Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 20...
Prof Michael Dickinson from Peter MacCallum Cancer Centre in Melbourne, Australia, and Dr Laurie H Sehn from the University of British Columbia in Vancouver, Canada, discuss clinical cases and recent findings from the 20...
Fill in the form below. Make sure to select both Country and Genres.
Send us a message below. We will get back to you within 24 hours.